Group A (PSA/biopsy) consists of ERSPC [3], PLCO Cancer Screening Trial [4,17], Cluster randomised trial of PSA testing for Prostate cancer (CAP) [18], and Early Prostate Cancer Detection Programme (EPCDP) [19]. This evidence concerns the gene KLK3 and cancer.